A SCOTTISH university has been given a £34.2 million funding boost to develop new medicines, cheaper drugs and innovative treatments for chronic diseases.

Strathclyde University has received the £11.4m cash injection, also supported with £22.8m of industry and charity contributions, from the Higher Education Funding Council for England (HEFCE) under the UK Research Partnership Investment Fund.

The money will be used to boost research underway at the Strathclyde-led EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation (CMAC).

Professor Sir Jim McDonald, Principal of Strathclyde University, said the fresh funding would help cement the centre's place as a world-class research facility.

He added: "This national facility is an excellent example of Strathclyde's ability to deliver innovation by working creatively with industry and our academic partners at the Universities of Bath, Cambridge, Edinburgh, Glasgow, Heriot-Watt, and Loughborough.

"The Centre's internationally-leading research team are working to establish a world-class facility to accelerate innovative technology delivery and establish new supply chains for medicines.

"The funding award announced by HEFCE today will further strengthen the contribution of CMAC to economic growth, and will maximise its impact on the international competitiveness of a vital UK manufacturing sector."

Four other projects involving the University of Cambridge, University College London, the University of Manchester and the University of Sheffield also received funding.